Journal article
Investigating sodium valproate as a treatment for McArdle disease in sheep
Neuromuscular Disorders, Vol.25(2), pp.111-119
2015
Abstract
McArdle disease is due to an absence of the enzyme muscle glycogen phosphorylase and results in significant physical impairment in humans. We hypothesised that sodium valproate, an HDAC inhibitor, might have the ability to up-regulate the enzyme. We treated McArdle sheep with sodium valproate given enterically at 20-60 mg/kg body wt. Compared with untreated control animals, there was increased expression of phosphorylase in muscle fibres. The response was dose dependent and reached a maximum 2 hours after the application and increased with repeated applications. Improvement in mobility could not be demonstrated. These findings suggest that sodium valproate is a potential therapeutic treatment for McArdle disease.
Details
- Title
- Investigating sodium valproate as a treatment for McArdle disease in sheep
- Authors/Creators
- J.Mc.C. Howell (Author/Creator)E. Dunton (Author/Creator)K.E. Creed (Author/Creator)R. Quinlivan (Author/Creator)C. Sewry (Author/Creator)
- Publication Details
- Neuromuscular Disorders, Vol.25(2), pp.111-119
- Publisher
- Elsevier BV
- Identifiers
- 991005544942307891
- Copyright
- © 2014 Elsevier B.V.
- Murdoch Affiliation
- School of Veterinary and Life Sciences
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
183 File views/ downloads
54 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.271 Lysosomal Storage Disorders
- 1.271.2265 Glycogen Storage Diseases
- Web Of Science research areas
- Clinical Neurology
- Neurosciences
- ESI research areas
- Neuroscience & Behavior